Contact Us
Cecolin 9 Info
Join IX

Media

Press Releases Colincare Media Coverage Assets Library
Innovax to Showcase Cecolin 9 at IPVS 2025, Toward a New Era of Cervical Cancer Elimination
Press Releases
September 23, 2025

Innovax to Showcase Cecolin 9 at IPVS 2025, Toward a New Era of Cervical Cancer Elimination
Ten-Year Efficacy Data Published: Long-Term Follow-Up of Pivotal Trial of Cecolin Demonstrates Durable Efficacy and Immunopersistence
Press Releases
September 15, 2025

Ten-Year Efficacy Data Published: Long-Term Follow-Up of Pivotal Trial of Cecolin Demonstrates Durable Efficacy and Immunopersistence
Cecolin 9 Makes History with Global First Dose
Press Releases
September 09, 2025

Cecolin 9 Makes History with Global First Dose
Three-Year Follow-Up Data Published: Head-to-Head Study of Cecolin 9 vs. A Marketed HPV 9-Valent Vaccine in The Lancet Regional Health – Western Pacific
Press Releases
September 04, 2025

Three-Year Follow-Up Data Published: Head-to-Head Study of Cecolin 9 vs. A Marketed HPV 9-Valent Vaccine in The Lancet Regional Health – Western Pacific
INNOVAX’s HPV 9-Valent Vaccine: First Batch Released, Now on Market
Press Releases
August 22, 2025

INNOVAX’s HPV 9-Valent Vaccine: First Batch Released, Now on Market
Innovax Honored with China Patent Gold Award!
Press Releases
June 13, 2025

Innovax Honored with China Patent Gold Award!
Cecolin 9 for Public Cecolin 9 for HCPs Vaccine Portfolio Contact Us Media Report an Adverse Event
Copyright © 2026 Xiamen Innovax Biotech Co., Ltd. All rights reserved. 闽ICP备05033276号-3 闽公网安备 35020502000554号 Terms of Use Privacy Policy